Answers are grounded in this paper and cite their sources.
With the outbreak of Coronavirus Disease 2019 (COVID-19), blood drives have been cancelled, resulting in significantly fewer donations. However, blood components are still being used to treat patients with acute and chronic hemorrhage, trauma, cancer, hematologic disorders and even COVID-19 with disseminated intravascular coagulation. Consequently, national and local blood supplies will dwindle and may become critically limited.
No takes yet. Share an insight, caveat, or question.
Okocha et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: